aTyr Pharma Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year	Current	2023	2022	2021	2020	2019	2018 - 2013
Market Capitalization	114	83	64	208	39	16	Upgrade
Market Cap Growth	-	29.97%	-69.40%	428.49%	142.15%	9.00%	Upgrade
Enterprise Value	40	-4	6	101	10	-3	Upgrade
PE Ratio	-2.45	-1.64	-1.40	-6.15	-2.42	-0.69	Upgrade
PS Ratio	193.65	233.91	6.12	-	3.76	38.44	Upgrade
PB Ratio	1.35	0.91	0.89	1.90	1.24	0.77	Upgrade
P/FCF Ratio	-2.28	-2.21	-1.47	-6.25	-2.54	-0.81	Upgrade
P/OCF Ratio	-2.40	-2.49	-1.52	-6.28	-2.57	-0.81	Upgrade
EV/Sales Ratio	68.51	-11.29	0.55	-	0.94	-7.56	Upgrade
EV/EBITDA Ratio	-1.14	0.08	-0.13	-3.11	-0.66	0.14	Upgrade
EV/EBIT Ratio	-1.09	0.08	-0.13	-2.99	-0.61	0.14	Upgrade
EV/FCF Ratio	-1.01	0.11	-0.13	-3.04	-0.63	0.16	Upgrade
Debt / Equity Ratio	0.17	0.17	0.16	0.01	0.07	0.55	Upgrade
Debt / EBITDA Ratio	-0.28	-0.32	-0.26	-0.04	-0.15	-0.53	Upgrade
Debt / FCF Ratio	-0.24	-0.40	-0.27	-0.04	-0.14	-0.59	Upgrade
Quick Ratio	5.64	6.34	5.85	18.02	5.75	2.42	Upgrade
Current Ratio	6.07	6.27	5.83	18.89	6.06	2.47	Upgrade
Asset Turnover	0.01	0.00	0.11	0	0.23	0.01	Upgrade
Return on Equity (ROE)	-56.80%	-49.70%	-54.30%	-42.50%	-45.70%	-87.70%	Upgrade
Return on Assets (ROA)	-43.90%	-39.10%	-46.20%	-39.30%	-35.60%	-52.90%	Upgrade
Return on Capital (ROIC)	-59.61%	-51.93%	-55.91%	-30.73%	-46.95%	-69.81%	Upgrade
Earnings Yield	-47.36%	-61.03%	-71.36%	-16.27%	-41.30%	-145.50%	Upgrade
FCF Yield	-50.92%	-45.32%	-68.23%	-16.00%	-39.42%	-123.54%	Upgrade
Buyback Yield / Dilution	-57.72%	-88.63%	-48.94%	-108.30%	-172.98%	-56.66%	Upgrade
Total Shareholder Return	-57.72%	-88.63%	-48.94%	-108.30%	-172.98%	-56.66%	Upgrade

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).